ОНКОЛОГИЯ
Лечение нейтропении
русский
Лечение нейтропении
/assets/ct/28ada02fb0/images/syn_placeholder_sqr.png

Онкология

Лечение нейтропении

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. (открывается в новом окне)

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer.

Источник‎: Eur J Cancer 2011;47(1):8-32.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. (открывается в новом окне)

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.

Источник‎: Clin Infect Dis 2011;52(4):427-31.

Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (открывается в новом окне)

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology.

Источник‎: J Clin Oncol 2015;33(28):3199-212.